Cargando...
Potential new uses of non–vitamin K antagonist oral anticoagulants to treat and prevent stroke
BACKGROUND: Non–vitamin K antagonist oral anticoagulant (NOAC) drugs are at least equivalent to warfarin for ischemic stroke prevention in patients with atrial fibrillation and have a lower risk of intracranial hemorrhage. The role of these agents in the prevention and treatment of other types of ce...
Gardado en:
| Publicado en: | Neurology |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4603598/ https://ncbi.nlm.nih.gov/pubmed/26187229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001817 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|